I thought studies include Remdesivir and Hydroxycloroquine showed negative results. Why would we be buying up Remdesivir when Dexamethasone is the new hot drug with good clinical results?
Remdesivir reduces hospital stay but does not reduce mortality. It costs a lot and is hard to make.
Dexamethasone is cheap, easy to make, and reduces mortality. We don't want remdesivir, which is why you're not seeing regulatory action to seize control of the rights.
Dexamethasone is cheap, easy to make, and reduces mortality. We don't want remdesivir, which is why you're not seeing regulatory action to seize control of the rights.
https://www.nihr.ac.uk/news/first-drug-to-reduce-mortality-i...